|
End-of-day quote
Dhaka S.E.
10/09/2026
|
5-day change | 1st Jan Change | ||
| 756.00 BDT | +0.47% |
|
+1.00% | +6.78% |
| Market Cap | 1.82B 14.71M 12.65M 11.93M 10.87M 20.32M 1.41B 20.51M 142M 54.7M 713M 55.23M 54.03M 2.27B | P/E 2024 |
189x | P/E 2025 | 369x |
|---|---|---|---|---|---|
| Enterprise Value | 2.32B 18.81M 16.18M 15.26M 13.9M 25.99M 1.8B 26.23M 182M 69.96M 912M 70.64M 69.09M 2.9B | EV / Sales 2024 |
10.4x | EV / Sales 2025 | 10.7x |
| Free-Float |
22.75% | Yield 2024 |
0.13% | Yield 2025 | 0.12% |
| 1 day | +0.47% | ||
| 1 week | +1.00% | ||
| Current month | +0.08% | ||
| 1 month | -6.05% | ||
| 3 months | -2.89% | ||
| 6 months | -2.22% | ||
| Current year | +6.78% |
| 1 week | 750 |  | 799.9 |
| 1 month | 742.2 | | 808 |
| Current year | 689 | | 847 |
| 1 year | 681 | | 847 |
| 3 years | 650 | | 1,302.3 |
| 5 years | 375.3 | | 1,302.3 |
| 10 years | 353 | | 1,302.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
Nurjehan Hudda
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.47% | +1.00% | -9.25% | +14.95% | 14.71M | |
| -0.21% | -3.66% | +16.92% | +64.62% | 47.02B | |
| -1.80% | -5.95% | +34.69% | +111.80% | 39.94B | |
| -0.85% | -3.15% | +7.94% | +77.95% | 11.82B | |
| +0.75% | -2.80% | -11.49% | +10.34% | 11.57B | |
| +0.19% | +0.38% | +19.41% | +137.73% | 9.18B | |
| -0.40% | -5.12% | +34.30% | -16.30% | 7.2B | |
| -0.82% | -1.83% | +14.11% | +210.87% | 7.22B | |
| -0.72% | -2.50% | +24.28% | +32.80% | 7.32B | |
| -1.43% | -1.34% | -44.42% | +21.01% | 5.2B | |
| Average | -0.48% | -2.43% | +8.65% | +66.58% | 14.65B | |
| Weighted average by Cap. | -0.70% | -3.24% | +17.86% | +78.95% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 219M 1.78M 1.53M 1.44M 1.31M 2.45M 170M 2.48M 17.17M 6.61M 86.15M 6.67M 6.53M 274M | 231M 1.87M 1.61M 1.52M 1.38M 2.58M 179M 2.6M 18.05M 6.95M 90.57M 7.01M 6.86M 288M |
| Net income | 9.68M 78.45K 67.46K 63.65K 57.99K 108K 7.5M 109K 758K 292K 3.8M 295K 288K 12.08M | 5.31M 43.01K 36.99K 34.9K 31.79K 59.44K 4.11M 59.98K 416K 160K 2.09M 162K 158K 6.63M |
| Net Debt | 445M 3.6M 3.1M 2.92M 2.66M 4.98M 344M 5.02M 34.81M 13.4M 175M 13.53M 13.23M 555M | 506M 4.1M 3.53M 3.33M 3.03M 5.67M 392M 5.72M 39.64M 15.26M 199M 15.4M 15.07M 632M |
Employees
474
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | BDT 756.00 | +0.47% | 2,222 |
| 09/09/26 | BDT 752.50 | -0.05% | 878 |
| 08/09/26 | BDT 752.90 | -0.57% | 1,138 |
| 07/09/26 | BDT 757.20 | -0.26% | 952 |
| 06/09/26 | BDT 759.20 | +1.77% | 882 |
- Stock Market
- Stocks
- AMBEEPHA Stock
Select your edition
All financial news and data tailored to specific country editions
